We are live on ! Find out more
ACIU icon

AC Immune

40 hedge funds and large institutions have $63.3M invested in AC Immune in 2026 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 12 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

73% more call options, than puts

Call options by funds: $425K | Put options by funds: $245K

8% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 12

0.3% less ownership

Funds ownership: 24.04% → 23.74% (-0.3%)

7% less funds holding

Funds holding: 43 → 40 (-3)

29% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 7

44% less capital inflows, than outflows

Capital inflows: $930K | Capital outflows: $1.66M

Holders
40
Holders Change
-3
Holders Change %
-6.98%
% of All Funds
0.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
13
Reduced
12
Closed
7
Calls
$425​K
Puts
$245​K
Net Calls
+$180​K
Net Calls Change
+$251​K

ACIU Hedge Fund Activity: Q3 2026 in Review

40 of the 8,199 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q3 2026, worth a combined $63.3M — up 8.7% from $58.2M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of ACIU and 5 opened new positions — a net loss of 2 holders — while 12 trimmed existing stakes and 13 added.

The largest buyer was Two Sigma Investments, adding an estimated $416K. The largest seller was Millennium Management, cutting an estimated $983K.

  • 40 institutional investors held AC Immune (ACIU) as of Q3 2026, down from 43 in Q2 2026.
  • Funds reported $63.3M of AC Immune stock for Q3 2026, up 8.7% quarter-over-quarter.
  • 5 funds opened new AC Immune positions in Q3 2026 and 7 closed out, a net change of -2 holders.
  • The largest AC Immune buyer in Q3 2026 was Two Sigma Investments, an estimated $416K added.
  • The largest AC Immune seller in Q3 2026 was Millennium Management, an estimated $983K sold.

Based on aggregated 13F filings for Q3 2026.